Alejandra Beatriz Cardillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alejandra Beatriz Cardillo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Ana M. Giulietti
Universidad de Buenos Aires
3 shared publications- Javier Palazon
Department of Biology, Healthcare and the Environment, University of Barcelona, 08028 Barcelona, Spain
2 shared publications Juan M. Minoia
Facultad de Farmacia Y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología, Universidad de Buenos Aires, Buenos Aires, Argentina
2 shared publicationsJulián Rodriguez Talou
Cátedra de Biotecnología-Instituto Nanobiotec (UBA/Conicet), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junin 954 Ciudad, Autonoma de Buenos Aires, Buenos Aires, Argentina
2 shared publicationsJulián Rodríguez Talou
Facultad de Farmacia Y Bioquímica, Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Biotecnología, Universidad de Buenos Aires, Buenos Aires, Argentina
2 shared publications- Ana Maria Giulietti
Programa de Pós-graduação em Botânica, Departamento de Ciências Biológicas, Universidade Estadual de Feira de Santana, Feira De Santana, Brazil
1 shared publication
Latest Publications
- 26 April 2023
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 107 (11) , 3459-3478
Recycling of hyoscyamine 6β-hydroxylase for the in vitro production of anisodamine and scopolamine
The tropane alkaloids hyoscyamine, anisodamine, and scopolamine are extensively used medicines. In particular, scopolamine has the greatest value in the ma
- 26 April 2023
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 107 (11) , 3459-3478
Recycling of hyoscyamine 6β-hydroxylase for the in vitro production of anisodamine and scopolamine
The tropane alkaloids hyoscyamine, anisodamine, and scopolamine are extensively used medicines. In particular, scopolamine has the greatest value in the ma
- 28 June 2020
- Published by Springer Nature
- p. 123-132
Tropane Alkaloid Production by the Establishment of Hairy Root Cultures of Brugmansia candida and Elicitation
- 28 June 2020
- Published by Springer Nature
- p. 123-132
Tropane Alkaloid Production by the Establishment of Hairy Root Cultures of Brugmansia candida and Elicitation
- 24 April 2016
- Published by Springer Nature
- Vol. 1391, 173-186
Establishment, Culture, and Scale-up of Brugmansia candida Hairy Roots for the Production of Tropane Alkaloids
Brugmansia candida (syn. Datura candida) is a South American native plant that produces tropane alkaloids. Hyoscyamine, 6β-hydroxyhyoscyamine (anisodamine), and scopolamine are the most important ones due to their anticholinergic activity. These bioactive compounds have been historically and widely applied in medicine and their demand is continuous. Their chemical synthesis is costly and complex, and thereby, these alkaloids are industrially produced from natural producer plants. The production of these secondary metabolites by plant in vitro cultures such as hairy roots presents certain advantages over the natural source and chemical synthesis. It is well known that hairy roots produced by Agrobacterium rhizogenes infection are fast-growing cultures, genetically stable and able to grow in hormone-free media. Additionally, recent progress achieved in the scaling up of hairy root cultures makes this technology an attractive tool for industrial processes. This chapter is focused on the methods for the induction and establishment of B. candida hairy roots. In addition, the scaling up of hairy root cultures in bioreactors and tropane alkaloid analysis is discussed.
- 24 April 2016
- Published by Springer Nature
- Vol. 1391, 173-186
Establishment, Culture, and Scale-up of Brugmansia candida Hairy Roots for the Production of Tropane Alkaloids
Brugmansia candida (syn. Datura candida) is a South American native plant that produces tropane alkaloids. Hyoscyamine, 6β-hydroxyhyoscyamine (anisodamine), and scopolamine are the most important ones due to their anticholinergic activity. These bioactive compounds have been historically and widely applied in medicine and their demand is continuous. Their chemical synthesis is costly and complex, and thereby, these alkaloids are industrially produced from natural producer plants. The production of these secondary metabolites by plant in vitro cultures such as hairy roots presents certain advantages over the natural source and chemical synthesis. It is well known that hairy roots produced by Agrobacterium rhizogenes infection are fast-growing cultures, genetically stable and able to grow in hormone-free media. Additionally, recent progress achieved in the scaling up of hairy root cultures makes this technology an attractive tool for industrial processes. This chapter is focused on the methods for the induction and establishment of B. candida hairy roots. In addition, the scaling up of hairy root cultures in bioreactors and tropane alkaloid analysis is discussed.
- 8 May 2013
- Published by Springer Nature in Plant Cell, Tissue and Organ Culture (PCTOC)
- Vol. 114 (3) , 305-312
Influence of hairy root ecotypes on production of tropane alkaloids in Brugmansia candida
- 8 May 2013
- Published by Springer Nature in Plant Cell, Tissue and Organ Culture (PCTOC)
- Vol. 114 (3) , 305-312
Influence of hairy root ecotypes on production of tropane alkaloids in Brugmansia candida
- 1 September 2012
- Published by Elsevier in New Biotechnology
- Vol. 29, S173
Influence of hairy root ecotype and rolC expression in the biotechnological production of bioactive compounds
- 1 September 2012
- Published by Elsevier in New Biotechnology
- Vol. 29, S173
Influence of hairy root ecotype and rolC expression in the biotechnological production of bioactive compounds
- 31 October 2008
- Published by Elsevier in Journal of Biotechnology
- Vol. 136, S377
Hyoscyamine 6-β-hydroxylase, a recombinant biocatalyst for the industrial production of scopolamine
- 31 October 2008
- Published by Elsevier in Journal of Biotechnology
- Vol. 136, S377
Hyoscyamine 6-β-hydroxylase, a recombinant biocatalyst for the industrial production of scopolamine
- Open Access
- 27 May 2008
- Published by Springer Nature in Microbial Cell Factories
- Vol. 7 (1) , 17
Expression of Brugmansia candida Hyoscyamine 6beta-Hydroxylase gene in Saccharomyces cerevisiae and its potential use as biocatalyst
Background: Tropane alkaloids, mainly hyoscyamine and scopolamine, are widely used in medicine due to their anticholinergic activity. Scopolamine has a higher demand being the more valuable alkaloid due to its fewer side effects and higher physiological activity. Anisodamine (6β-hydroxyhyoscyamine) is the intermediate in the conversion of hyoscyamine into scopolamine. Current studies report that this alkaloid is potentially applicable in medicine. The gene that codifies for Hyoscyamine 6-β hydroxylase, the enzyme responsible for hyoscyamine hydroxylation and epoxidation, leading to scopolamine was isolated from Brugmansia candida. Results: The h6h cDNA was cloned into pYES2.1 and pYES2.1/V5-His-TOPO vectors to produce an untagged and a tagged protein, respectively. The H6H enzyme was produced in Saccharomyces cerevisiae in order to obtain a biological catalyst for potential industrial applications. Protein extracts of the induced yeast were analyzed by Western blot. The expression was detected 4 h after induction and no degradation was observed during the period assayed. The tagged and the untagged proteins were able to transform hyoscyamine, showing a functional expression of the h6h cDNA. Conclusion: The strains obtained in this work are promising and potentially applicable in biocatalytic processes.
- 27 May 2008
- Published by Springer Nature in Microbial Cell Factories
- Vol. 7 (1) , 17
Open AccessExpression of Brugmansia candida Hyoscyamine 6beta-Hydroxylase gene in Saccharomyces cerevisiae and its potential use as biocatalyst
Background: Tropane alkaloids, mainly hyoscyamine and scopolamine, are widely used in medicine due to their anticholinergic activity. Scopolamine has a higher demand being the more valuable alkaloid due to its fewer side effects and higher physiological activity. Anisodamine (6β-hydroxyhyoscyamine) is the intermediate in the conversion of hyoscyamine into scopolamine. Current studies report that this alkaloid is potentially applicable in medicine. The gene that codifies for Hyoscyamine 6-β hydroxylase, the enzyme responsible for hyoscyamine hydroxylation and epoxidation, leading to scopolamine was isolated from Brugmansia candida. Results: The h6h cDNA was cloned into pYES2.1 and pYES2.1/V5-His-TOPO vectors to produce an untagged and a tagged protein, respectively. The H6H enzyme was produced in Saccharomyces cerevisiae in order to obtain a biological catalyst for potential industrial applications. Protein extracts of the induced yeast were analyzed by Western blot. The expression was detected 4 h after induction and no degradation was observed during the period assayed. The tagged and the untagged proteins were able to transform hyoscyamine, showing a functional expression of the h6h cDNA. Conclusion: The strains obtained in this work are promising and potentially applicable in biocatalytic processes.